Sinopharm Holdings

Sinopharm Holdings Co., Ltd. (*) is affiliated to China National Pharmaceutical Group Corporation (*), a medical and health industry group directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. The company was established in January 2003 and was successfully listed in Hong Kong in September 2009 (01099.HK). In 2021, it ranked 22nd in the Fortune China 500. Sinopharm Holdings Shandong Co., Ltd. was established in December 2009 and serves as the provincial-level management and sales platform of Sinopharm Holdings Co., Ltd. for the Shandong region. After more than ten years of steady development, its current sales scale has reached 20 billion yuan, making it a leading enterprise in the pharmaceutical distribution field in Shandong Province. The company currently has more than 4,000 employees and 52 legal entities, achieving a transformation from a single company to a group company. Sinopharm Holdings Shandong Co., Ltd. adheres to the corporate philosophy of 'Caring for Life, Nurturing Health', fully implements the 'Four New' development strategy of the headquarters, achieves full business format and full network coverage through strategic layout; leverages the multiplier effect of innovation through innovation-driven development to promote the development of the main business; unswervingly promotes the transformation of marketing (capability), accelerates the construction of a province-wide integrated platform, comprehensively enhances competitive advantages, and strives to become a first-class comprehensive medical and health service provider in Shandong Province.